norethindrone has been researched along with Hot Flashes in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (16.13) | 18.2507 |
| 2000's | 18 (58.06) | 29.6817 |
| 2010's | 7 (22.58) | 24.3611 |
| 2020's | 1 (3.23) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Hendy, A; Archer, DF; Barnhart, KT; Bradley, LD; Carr, BR; Dayspring, T; Feinberg, EC; Gillispie, V; Hurtado, S; Kim, J; Liu, R; Muneyyirci-Delale, O; Owens, CD; Schlaff, WD; Simon, JA; Wang, A; Watts, NB | 1 |
| Butler, R; Cheng, G; Gustafsson, JÅ; Landgren, BM; Warner, M; Wilczek, B | 1 |
| Dietrich, JE; Hendry, D; Sangi-Haghpeykar, H; Santos, M | 1 |
| Granqvist, CJ; Ipsen, HE; Kokot-Kierepa, M; Mattsson, LÅ | 1 |
| Cagnacci, A; D'Alterio, MN; Di Carlo, C; Melis, GB; Neri, M; Orrù, MM; Paoletti, AM | 1 |
| Azevedo, LH; Cunha, EP; Fernandes, CE; Ferreira, JA; Peixoto, S; Pompei, LM; Steiner, ML; Strufaldi, R | 1 |
| Fenton, A; Panay, N | 1 |
| Chwalisz, K; Stanczyk, FZ; Surrey, E | 1 |
| Keil, D; Lang, E; von Holst, T; Winkler, U | 1 |
| Jirapinyo, M; Jorgensen, LN; Manonai, J; Suchartwatnachai, C; Theppisai, U | 1 |
| Heikkinen, J; Mäenpää, J; Mattsson, LA; Skouby, SO; Timonen, U; Vaheri, R | 1 |
| Alessandrini, C; Arangino, S; Baldassari, F; Cagnacci, A; Landi, S; Volpe, A | 1 |
| Adaro, L; Albrecht, G; Baracat, EC; Bassol, S; Bayo, J; Blanco, S; Boccanera, R; Camargos, AF; Carranza-Lira, S; Celis-Gonzalez, C; da Fonseca, AM; da Sá, MF; de la Loza, FR; Gomez, G; Gurucharri, C; Llaca, V; Martinez, N; Murga, M; Murillo, A; Naranjo, C; Reyes-Marquez, R; Rios, PC; Sanchez, F; Santos, J; Santoyo, S; Sayegh, F; Siseles, N; Tempone, A; Tempone, LM; Tozzini, RI; Zarain, J | 1 |
| Adler, G; Galant, R; Maki, KC; Quinn, L; Witchger, MS; Young, D | 1 |
| Drosdzol, A; Kowalczyk, R; Nowosielski, K; Piela, B; Rozmus-Warcholińska, W; Skrzypulec, V; Walaszek, A | 1 |
| Gambacciani, M; Genazzani, AR; Spielmann, D | 1 |
| Pornel, B; Spielmann, D | 1 |
| Ellman, H; Rowan, JP; Simon, JA; Speroff, L | 1 |
| Bagnoli, VR; Cavalcanti, AL; Fonseca, AM; Paixão, JS; Penteado, SR; Pinotti, JA | 1 |
| Arguinzoniz, M; Dvorak, V; Ferreira, A; Genazzani, AR; Hamann, B; Heikkinen, J; Kawakami, FT; Mueck, AO; Samsioe, G; Sun, D; Suzin, J | 1 |
| Archer, DF; Gut, R; Lang, E; Panay, N; Ylikorkala, O | 1 |
| Franke, HR; Hammar, ML; Nijland, EA; Pornel, B; van de Weijer, P; von Mauw, EM | 1 |
| Baird, DT; Cameron, ST; Critchley, HO; Glasier, AF; Williams, AR | 1 |
| Arrenbrecht, S; Rozenberg, S; Ylikorkala, O | 1 |
| Christau, S; Garre, K; Hammar, M; Nathorst-Böös, J; Rud, T | 1 |
| Akkad, A; Al-Azzawi, F; Habiba, M; Mason, T; Wahab, M | 1 |
| Cassel, D; Dain, MP; Furst, KW; Hille, D; Notelovitz, M; Skarinsky, D; VandePol, C | 1 |
| Bruhat, M; Kainulainen, P; Rudolf, K; Timonen, U; Vaheri, R; Viitanen, A | 1 |
| al-Azzawi, F; Dillon, J; Hirvonen, E; Magaril, C; Pornel, B; Thompson, J; van der Mooren, MJ; Wahab, M; Ylikorkala, O | 1 |
| Chen, LH; Jorgensen, LN; Loh, FH; Yu, SL | 1 |
| Arce, JC; Baerug, U; Faber-Swensson, E; Heldaas, K; Larsen, S; Nordland, G; Norling, B; Winge, T | 1 |
2 review(s) available for norethindrone and Hot Flashes
| Article | Year |
|---|---|
The hormonal profile of norethindrone acetate: rationale for add-back therapy with gonadotropin-releasing hormone agonists in women with endometriosis.
Topics: Bone Density; Endometriosis; Estrogens; Female; Gonadotropin-Releasing Hormone; Hot Flashes; Humans; Lipoproteins, HDL; Norethindrone; Norethindrone Acetate; Osteoporosis; Pelvic Pain; Progesterone | 2012 |
Effects of low-dose norethindrone acetate plus ethinyl estradiol (0.5 mg/2.5 microg) in women with postmenopausal symptoms: updated analysis of three randomized, controlled trials.
Topics: Bone Density; Endometrial Hyperplasia; Estrogen Replacement Therapy; Ethinyl Estradiol; Female; Hot Flashes; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Randomized Controlled Trials as Topic | 2006 |
24 trial(s) available for norethindrone and Hot Flashes
| Article | Year |
|---|---|
Elagolix Treatment for Up to 12 Months in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas.
Topics: Adult; Bone Density; Double-Blind Method; Drug Therapy, Combination; Estradiol; Female; Gonadotropin-Releasing Hormone; Headache; Hot Flashes; Humans; Hydrocarbons, Fluorinated; Leiomyoma; Menorrhagia; Middle Aged; Nausea; Norethindrone; Pyrimidines; Quality of Life; Uterine Neoplasms | 2020 |
Clinical effect of hormonal replacement therapy with estradiol associated with noretisterone or drospirenone. A prospective randomized placebo controlled study.
Topics: Adipose Tissue; Androstenes; Body Composition; Body Water; Body Weight; Double-Blind Method; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Estrogens; Female; Hot Flashes; Humans; Insulin Resistance; Middle Aged; Mineralocorticoid Receptor Antagonists; Norethindrone; Postmenopause; Progesterone Congeners; Quality of Life; Treatment Outcome | 2015 |
Effect of abrupt discontinuation versus gradual dose reduction of postmenopausal hormone therapy on hot flushes.
Topics: Estradiol; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Placebos; Time Factors | 2010 |
Bleeding patterns in peri and postmenopausal women taking a continuous combined regimen of estradiol with norethisterone acetate or a conventional sequential regimen of conjugated equine estrogens with medrogestone.
Topics: Adult; Aged; Austria; Cohort Studies; Drug Administration Schedule; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Germany; Hot Flashes; Humans; Medrogestone; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Prospective Studies; Treatment Outcome; Uterine Hemorrhage | 2002 |
Effect of combined oral estrogen/progestogen preparation (Kliogest) on bone mineral density, plasma lipids and postmenopausal symptoms in HRT-naïve Thai women.
Topics: Administration, Oral; Aged; Bone Density; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Double-Blind Method; Drug Combinations; Estradiol; Estriol; Estrogen Replacement Therapy; Estrogens; Female; Hot Flashes; Humans; Middle Aged; Norethindrone; Osteoporosis, Postmenopausal; Progestins; Thailand; Treatment Outcome; Uterine Hemorrhage | 2003 |
A low-dose start in hormone replacement therapy provides a beneficial bleeding profile and few side-effects: randomized comparison with a conventional-dose regimen.
Topics: Aged; Contraceptive Agents, Female; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Uterine Hemorrhage | 2004 |
A comparison of the central effects of different progestins used in hormone replacement therapy.
Topics: Administration, Cutaneous; Anxiety; Body Temperature; Depression; Double-Blind Method; Estradiol; Female; Follow-Up Studies; Hormone Replacement Therapy; Hot Flashes; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnadienes; Placebos; Postmenopause; Progestins; Time Factors | 2004 |
The impact of a monophasic continuous estro-progestogenic treatment on Latin American menopausal women.
Topics: Administration, Oral; Adult; Anxiety; Contraceptives, Oral, Synthetic; Depression; Dizziness; Estradiol; Estrogen Replacement Therapy; Female; Headache; Heart Rate; Hot Flashes; Humans; Latin America; Lipids; Menopause; Middle Aged; Muscle Weakness; Norethindrone; Norethindrone Acetate; Paresthesia; Prospective Studies | 2005 |
A multicenter, open-label study to evaluate satisfaction and menopausal quality of life in women using transdermal estradiol/norethindrone acetate therapy for the management of menopausal signs and symptoms.
Topics: Administration, Cutaneous; Aged; Drug Combinations; Estradiol; Female; Hot Flashes; Humans; Hyperhidrosis; Middle Aged; Norethindrone; Norethindrone Acetate; Patient Satisfaction; Postmenopause; Quality of Life; Reproductive Control Agents | 2005 |
[The effect of transdermal hormone replacement therapy on vasomotor symptoms in perimenopausal women].
Topics: Administration, Cutaneous; Drug Administration Schedule; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Perimenopause; Poland; Severity of Illness Index; Time Factors; Treatment Outcome; Vasomotor System | 2004 |
Efficacy on climacteric symptoms of a continuous combined regimen of 1 mg 17beta-estradiol and trimegestone versus two regimens combining 1 or 2 mg 17beta-estradiol and norethisterone acetate.
Topics: Administration, Oral; Adult; Affect; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Promegestone; Prospective Studies; Quality of Life; Sweating | 2005 |
A study of the control of climacteric symptoms in postmenopausal women following sequential regimens of 1 mg 17beta-estradiol and trimegestone compared with a regimen containing 1 mg estradiol valerate and norethisterone over a two-year period.
Topics: Administration, Oral; Adult; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Promegestone; Prospective Studies; Quality of Life; Sleep Wake Disorders; Sweating; Uterine Hemorrhage | 2005 |
Monophasic estrogen-progestogen therapy and sexuality in postmenopausal women.
Topics: Adult; Cross-Over Studies; Double-Blind Method; Drug Combinations; Estradiol; Female; Hormone Replacement Therapy; Hot Flashes; Humans; Libido; Middle Aged; Norethindrone; Norethindrone Acetate; Personal Satisfaction; Postmenopause; Progesterone Congeners | 2007 |
One-year endometrial safety evaluation of a continuous combined transdermal matrix patch delivering low-dose estradiol-norethisterone acetate in postmenopausal women.
Topics: Administration, Cutaneous; Aged; Drug Therapy, Combination; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Middle Aged; Norethindrone; Postmenopause; Treatment Outcome | 2007 |
Ultra-low-dose estradiol and norethisterone acetate: effective menopausal symptom relief.
Topics: Adult; Aged; Contraceptives, Oral, Synthetic; Dose-Response Relationship, Drug; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Factor VII; Female; Fibrinogen; Hot Flashes; Humans; Hydrogen-Ion Concentration; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Severity of Illness Index; Vagina | 2007 |
Tibolone and low-dose continuous combined hormone treatment: vaginal bleeding pattern, efficacy and tolerability.
Topics: Aged; Contraceptives, Oral, Synthetic; Double-Blind Method; Drug Therapy, Combination; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens; Female; Hot Flashes; Humans; Metrorrhagia; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes | 2007 |
Comparison of continuous and sequential transdermal progestogen with sequential oral progestogen in postmenopausal women using continuous transdermal estrogen: vasomotor symptoms, bleeding patterns, and serum lipids.
Topics: Administration, Cutaneous; Administration, Oral; Cohort Studies; Estradiol; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Lipids; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Reference Values; Uterine Hemorrhage; Vasomotor System | 1997 |
A double-blind, randomised trial comparing the effects of tibolone and continuous combined hormone replacement therapy in postmenopausal women with menopausal symptoms.
Topics: Anabolic Agents; Double-Blind Method; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Menopause; Middle Aged; Norethindrone; Norpregnenes; Postmenopause; Progesterone Congeners; Sexual Behavior; Sweating; Uterine Hemorrhage; Vaginal Diseases | 1998 |
Continuous combined hormone replacement therapy compared with tibolone.
Topics: Climacteric; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Lipoproteins; Menstruation; Middle Aged; Minor Histocompatibility Loci; Norethindrone; Norpregnenes; Progesterone Congeners | 1999 |
Efficacy of continuous sequential transdermal estradiol and norethindrone acetate in relieving vasomotor symptoms associated with menopause.
Topics: Administration, Cutaneous; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Placebos; Progesterone Congeners; Sweating | 2000 |
Effective bleeding control and symptom relief by lower dose regimens of continuous combined hormone replacement therapy: a randomized comparative dose-ranging study.
Topics: Aged; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Dose-Response Relationship, Drug; Drug Therapy, Combination; Endometrium; Estradiol; Female; France; Germany; Hormone Replacement Therapy; Hot Flashes; Humans; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Patient Compliance; Surveys and Questionnaires; Treatment Outcome; Triglycerides; Uterine Hemorrhage | 2001 |
Acceptability and patterns of endometrial bleeding in estradiol-based HRT regimens: a comparative study of cyclical sequential combinations of trimegestone or norethisterone acetate.
Topics: Argentina; Double-Blind Method; Endometrium; Estradiol; Estrogen Replacement Therapy; Europe; Female; Hot Flashes; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Patient Satisfaction; Promegestone; Treatment Outcome; Uterine Hemorrhage | 2001 |
The efficacy of two dosages of a continuous combined hormone replacement regimen.
Topics: Aged; Alkaline Phosphatase; Amino Acids; Asian People; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Collagen; Collagen Type I; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Estradiol; Female; Hormone Replacement Therapy; Hot Flashes; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Osteoporosis, Postmenopausal; Peptides; Postmenopause; Prospective Studies; Singapore; Treatment Outcome; Triglycerides; Uterine Hemorrhage | 2002 |
Do combinations of 1 mg estradiol and low doses of NETA effectively control menopausal symptoms?
Topics: Estradiol; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Placebos; Uterine Hemorrhage | 1998 |
5 other study(ies) available for norethindrone and Hot Flashes
| Article | Year |
|---|---|
Effects of short-term estradiol and norethindrone acetate treatment on the breasts of normal postmenopausal women.
Topics: Aged; Breast; Cell Proliferation; Cholesterol, HDL; Cholesterol, LDL; Collagen; Contraceptives, Oral, Synthetic; Drug Therapy, Combination; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Female; Hot Flashes; Humans; Ki-67 Antigen; Mammography; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Receptors, Androgen; Receptors, Progesterone; Sweating | 2013 |
Retrospective review of norethindrone use in adolescents.
Topics: Adolescent; Child; Contraceptives, Oral, Synthetic; Contraindications; Estrogens; Female; Hot Flashes; Humans; Medication Adherence; Menorrhagia; Metrorrhagia; Mood Disorders; Nausea; Norethindrone; Retrospective Studies; Tertiary Care Centers; Treatment Refusal; Vomiting | 2014 |
Ultra-low-dose estradiol and norethisterone acetate: bleeding patterns and other outcomes over 52 weeks of therapy.
Topics: Contraceptives, Oral, Synthetic; Estradiol; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Norway; Prospective Studies; Quality of Life; Surveys and Questionnaires; Sweden; Treatment Outcome; Uterine Hemorrhage | 2015 |
Alternative regimens for endometrial protection ? Where are we now?
Topics: Androstenes; Antihypertensive Agents; Contraceptives, Oral, Synthetic; Estradiol; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Hypertension; Norethindrone; Postmenopause; Progesterone; Uterine Hemorrhage; Venous Thromboembolism | 2011 |
Continuous transdermal oestrogen and interrupted progestogen as a novel bleed-free regimen of hormone replacement therapy for postmenopausal women.
Topics: Administration, Cutaneous; Blood Pressure; Body Weight; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Immunohistochemistry; Middle Aged; Norethindrone; Patient Compliance; Pilot Projects; Progesterone Congeners; Uterine Hemorrhage | 1997 |